Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
Epimedium (6 trials)
huachansu pian (2 trials)
sorafenib (nexavar) (1 trial)
Breast Neoplasms (Phase 1)
Carcinoma (Phase 3)
Carcinoma, Hepatocellular (Phase 3)
Neoplasms (Phase 1)
Trials (6 total)
Trial APIs (3 total)